Medication info

Ocoscept Fast-Dissolving Tablet 10 mg (Donepezil Hydrochloride)

Prescription medicationOrally disintegrating TabletOralExpired
Ingredient · strength
Donepezil Hydrochloride Hydrate›10.43mg / 1 tablet
Manufacturer / importer
Os Korea Pharmaceutical Co., Ltd.
Appearance
Yellow round fast-dissolving tablet
Packaging
30 tablets/PTP [10 tablets/PTP pack x 3]
Approval status
Expired

MFDS item code 202004232 · Approved 2020.06.04

This product's status changed to Expired on 2025.06.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of symptoms of Alzheimer-type dementia
Who takes it
Adults · Children
Adult dose
○ Adults : Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Because donepezil reaches steady-state concentrations 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually decline; no rebound effect occurs after abrupt discontinuation. This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve; it may be taken with or without water. ○ Female patients 85 years of age and older who are underweight : Careful monitoring is required because adverse reactions occur frequently. Underweight elderly women should not exceed 5 mg daily.
Child dose
○ Children : There is no experience with use in children.

Ingredients

Manufacturer
Os Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer-type dementia

  • Symptoms of Alzheimer's type dementia
View approved original text

This medication is used for the treatment of Alzheimer's type dementia symptoms. It helps to improve memory decline and cognitive function impairment caused by dementia, enhancing the patient's daily living capabilities.

How to take

Adult dose

○ Adults : Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Because donepezil reaches steady-state concentrations 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually decline; no rebound effect occurs after abrupt discontinuation. This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve; it may be taken with or without water. ○ Female patients 85 years of age and older who are underweight : Careful monitoring is required because adverse reactions occur frequently. Underweight elderly women should not exceed 5 mg daily.

Child dose

○ Children : There is no experience with use in children.

Precautions

This medication contains aspartame, an artificial sweetener that is metabolized into phenylalanine in the body, and should not be used by patients with phenylketonuria. Patients with allergies to any components of this medication or hypersensitivity to donepezil hydrochloride or piperidine derivatives, pregnant women or those who may become pregnant, and breastfeeding women should not take this medication. Caution should be exercised in patients with heart disease, as this medication may stimulate the vagus nerve, potentially causing bradycardia or arrhythmia. Patients taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should be cautious, as increased gastric acid secretion and gastrointestinal motility could exacerbate symptoms. Patients with a history of asthma or obstructive lung disease should be careful, as bronchoconstriction and increased mucus secretion could worsen symptoms. Patients with Parkinson's disease or extrapyramidal disorders may be at risk of exacerbation of symptoms due to stimulation of cholinergic nerves by this medication. This medication contains Yellow No. 4 (Tartrazine), so patients with allergic reactions to this ingredient should use it with caution. During treatment with this medication, symptoms such as syncope, bradycardia, heart block, and myocardial infarction may occur due to cardiovascular-related adverse reactions, so immediate consultation with a physician is required if symptoms arise. There have been reports of gastrointestinal bleeding, peptic ulcers, hepatic dysfunction, cerebral hemorrhage, seizures, extrapyramidal disorder symptoms, neuroleptic malignant syndrome, rhabdomyolysis, respiratory distress, acute pancreatitis, acute renal failure, and unexplained sudden death; caution is required. This medication is used for the treatment of Alzheimer's type dementia, and the therapeutic effect should be evaluated regularly, and discontinuation should be considered if there is no efficacy. Patients with cardiovascular disease or a history of QT interval prolongation may need ECG monitoring due to the risk of cardiac arrhythmias. This medication may affect driving or the ability to operate machinery, so care should be taken during initial doses or dosage adjustments. Pregnant women should not use it unless absolutely necessary, and breastfeeding women are advised to discontinue breastfeeding while taking this medication. This medication is metabolized by the CYP3A4 and CYP2D6 enzymes, so be cautious of drug interactions with medications that inhibit or induce these enzymes. In case of overdose, symptoms such as nausea, vomiting, sweating, bradycardia, hypotension, respiratory depression, and seizures may occur, and antidotes such as atropine may be needed. This medication, when administered as a fast-dissolving tablet, should be placed on the tongue to dissolve and taken with saliva or water, and should be stored out of reach of children and maintained in its packaging to avoid discoloration from light exposure.

Side effects

  • Syncope
  • bradycardia
  • heart block
  • QT interval prolongation
  • myocardial infarction
  • heart failure
  • peptic ulcer
  • perforated duodenal ulcer
  • gastrointestinal bleeding
  • hepatitis
Show 227 more
  • liver dysfunction
  • jaundice
  • cerebral seizure
  • epilepsy
  • convulsions
  • cerebral hemorrhage
  • cerebrovascular disorder
  • motor disability
  • ataxia
  • movement disorder
  • dystonia
  • tremor
  • involuntary movement
  • gait disturbance
  • abnormal posture
  • speech disorder
  • akinetic mutism
  • extreme muscle rigidity
  • dysphagia
  • tachycardia
  • blood pressure fluctuation
  • sweating
  • rhabdomyolysis
  • myalgia
  • weakness
  • dyspnea
  • acute pancreatitis
  • acute renal failure
  • sudden death
  • cold
  • loss of appetite
  • hallucinations
  • excitation
  • aggressive behavior
  • anxiety disorder
  • insomnia
  • drowsiness
  • increased libido
  • talking too much
  • mania
  • nightmares
  • nervousness
  • nonsense
  • delusions
  • depression
  • confusion
  • indifference
  • hyperactivity
  • sexual desire
  • hypersexuality
  • dizziness
  • tremor
  • seizure
  • stupor
  • pleuritic chest pain
  • bradycardia
  • palpitations
  • sinoatrial block
  • atrioventricular block
  • hypertension
  • hypotension
  • atrial fibrillation
  • torsades de pointes
  • ECG QT interval prolongation
  • diarrhea
  • nausea
  • vomiting
  • abdominal disorder
  • gastrointestinal bleeding
  • gastric and duodenal ulcer
  • constipation
  • salivation
  • fecal incontinence
  • hepatitis
  • rash
  • itching
  • muscle cramps
  • myalgia
  • urinary incontinence
  • polyuria
  • urinary retention
  • headache
  • fatigue
  • pain
  • toothache
  • facial flushing
  • malaise
  • asthenia
  • edema
  • fever
  • decreased body temperature
  • decreased hematocrit
  • leukopenia
  • anemia
  • thrombocytopenia
  • petechiae
  • abnormal dreams
  • thoughts
  • headache
  • pain
  • back pain
  • fever
  • chest pain
  • hypertension
  • bleeding
  • syncope
  • constipation
  • gastroenteritis
  • fecal incontinence
  • indigestion
  • increased γ-GT
  • gastritis
  • dysphagia
  • periodontitis
  • gastric ulcer
  • periodontal abscess
  • abdominal bloating
  • liver dysfunction
  • belching
  • esophagitis
  • anal bleeding
  • diabetes
  • anemia
  • leukocytosis
  • weight loss
  • peripheral edema
  • edema
  • increased LDH
  • increased alkaline phosphatase
  • hypercholesterolemia
  • hypokalemia
  • hypoglycemia
  • weight gain
  • hyperbilirubinemia
  • increased BUN
  • B12 deficiency anemia
  • cachexia
  • increased creatinine
  • gout
  • hyponatremia
  • hypoalbuminemia
  • iron deficiency anemia
  • increased AST
  • increased ALT
  • arthritis
  • arthrosis
  • bone fracture
  • arthralgia
  • leg cramps
  • osteoporosis
  • myalgia
  • agitation
  • anxiety
  • tremor
  • convulsion
  • psychotic symptoms
  • gait disturbance
  • flat effect
  • dizziness
  • delusions
  • dream abnormalities
  • cerebrovascular abnormalities
  • increased salivation
  • ataxia
  • euphoric feeling
  • vasodilation
  • cerebral hemorrhage
  • cerebral infarction
  • cerebral ischemia
  • dementia
  • extrapyramidal symptoms
  • generalized tonic-clonic seizure
  • hemiplegia
  • hypertonia
  • decreased activity
  • pharyngitis
  • pneumonia
  • increased cough
  • bronchitis
  • dyspnea
  • rhinitis
  • asthma
  • rash
  • skin ulcer
  • itching
  • psoriasis
  • skin discoloration
  • shingles
  • dry skin
  • sweating
  • hives
  • vesicular rash
  • conjunctivitis
  • glaucoma
  • visual disturbances
  • ear pain
  • tearing abnormalities
  • urinary tract infection
  • cystitis
  • hematuria
  • diabetes
  • vaginitis
  • urination disorders
  • polyuria
  • proteinuria
  • abdominal pain
  • agitation
  • cholecystitis
  • confusion
  • convulsion
  • hallucination
  • heart block
  • hemolytic anemia
  • hepatitis
  • hyponatremia
  • neuroleptic malignant syndrome
  • pancreatitis
  • rash
  • nausea
  • vomiting
  • hypersalivation
  • sweating
  • hypotension
  • respiratory depression
  • weakness
  • convulsion
  • symptoms of muscular weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air entry, ideally at room temperature between 1°C and 30°C. Proper storage will help maintain efficacy and prevent degradation.

Appearance and packaging

Appearance

Yellow round fast-dissolving tablet

Package unit

30 tablets/PTP [10 tablets/PTP pack x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.